OCERA Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire OCERA Therapeutics, Inc.
Quantité totale PI 38
Rang # Quantité totale PI 38 020
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 346 041
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

7 0
12 1
17 0
1
 
Dernier brevet 2021 - Uses of ornithine phenylacetate ...
Premier brevet 1999 - Combinatorial synthesis of libra...
Dernière marque 2016 - OCERA
Première marque 2006 - OCERA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2021 Invention Uses of ornithine phenylacetate for treating hyperammonemia. Embodiments of the present disclosur...
2020 Invention Dosages and uses of ornithine phenylacetate for treating hyperammonemia. Embodiments of the prese...
Invention Methods of assessing and treating hepatic encephalopathy. The present disclosure relates to metho...
2018 Invention Processes of making l-ornithine phenylacetate. Embodiments of the present disclosure are related ...
Invention Macrocyclic ghrelin receptor modulators and methods of using the same. The present invention prov...
2016 Invention Formulation of l-ornithine phenylacetate. Some embodiments of the present application are directe...
Invention Macrocyclic modulators of the ghrelin receptor. The present invention provides novel conformatio...
Invention Treatment and prevention of neuronal cell loss using l-ornithine in combination with at least one...
Invention Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phe...
P/S Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related condi...
Invention Formulations of l-ornithine phenylacetate. Some embodiments of the present application are direct...
2015 Invention Intermediates for macrocyclic compounds. The present invention is directed to novel macrocyclic c...
Invention Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery. A library...
2014 Invention Macrocyclic modulators of the ghrelin receptor. The present invention provides novel conformation...
2011 Invention Methods of making l-ornithine phenyl acetate. Disclosed herein are processes for making L-ornithi...
Invention Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor. The present inv...
Invention Processes for intermediates for macrocyclic compounds. The present invention is directed to novel...
Invention Spatially-defined macrocyclic compounds useful for drug discovery. Novel spatially-defined macroc...
2010 Invention Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same. The...
Invention Phenylacetate and/or phenylbutyrate (not ornithine) for reducing portal blood pressure. The prese...
Invention Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome. Adsorbent car...
Invention Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetat...
Invention Use of adsorbent carbon microspheres for the treatment of pruritus. Disclosed herein are methods ...
Invention L-ornithine phenyl acetate and methods of making thereof. Disclosed herein are crystalline forms ...
2009 Invention Methods of using macrocyclic modulators of the ghrelin receptor. The present invention provides n...
Invention Spatially-defined macrocycles incorporating peptide bond surrogates. Novel spatially-defined macr...
Invention Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor. The present invention pro...
2008 Invention Use of adsorbent carbon microspheres to treat pouchitis. Disclosed herein is the use of adsorben...
Invention Use of adsorbent carbon microspheres to treat pouchitis. Disclosed herein is the use of adsorbent...
2007 Invention Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility dis...
Invention Use of adsorbent carbon microspheres to treat intestinal bacterial infections. Disclosed herein ...
Invention Use of adsorbent carbon microspheres to treat gastroesophogeal reflux disease. Disclosed herein ...
Invention Use of adsborbent carbon microspheres (ast-120) to treat gastroesophogeal reflux disease or sympt...
Invention Use of adsborbent carbon microspheres to treat intestinal bacterial infections. Disclosed herein ...
Invention Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal m...
2006 P/S Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, cardio-vascular, gastro...